Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?

To: varoujik who wrote (994)	7/27/2000 6:24:25 PM
From: Adam Nash	Read Replies (1) \| Respond to of 1906

Hey, I didn't give you much to work on. The Motley Fool (http://www.fool.com/) has several excellent write-ups on the coming drug pipeline and other issues, since Amgen is in their Rule Breaker portfolio. Recently, they claimed that they thought with volatility, they would like to pick up more shares in the 50s. I would agree that 50s would be a very attractive price. However, I am not sure we'll get a gift horse like that again, especially if the litigation resolves favorably in September.